Thomas Blaettler
Chief medical Officer at Orphazyme
neurology
Orphazyme
Denmark
Biography
Dr. Thomas Blaettler, M.D, Ph.D. has been the Chief Medical Officer of Orphazyme ApS since September 27, 2016. Dr. Blaettler headed a late-stage programme in rare disease indication spinal muscular atrophy at Roche. Dr. Blaettler has extensive clinical development and leadership experience. Dr. Blaettler is a Certified Neurologist.
Research Interest
Spinal muscular atrophy,clinical development
